{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T06:58:26Z","timestamp":1760597906137,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000801","name":"Bayer HealthCare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.thromres.2019.08.020","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T02:07:04Z","timestamp":1566439624000},"page":"101-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["DTI\/DXI interferences with global coagulation tests in emergency hospital admissions - Results of the prospective Dresden NOAC Registry (NCT01588119)"],"prefix":"10.1016","volume":"182","author":[{"given":"L.","family":"Wunder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Tittl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Marten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Beyer-Westendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2019.08.020_bb0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2016.04.019","article-title":"Direct oral anticoagulant drug level testing in clinical practice: a single institution experience","volume":"143","author":"Martin","year":"2016","journal-title":"Thromb. Res."},{"issue":"19","key":"10.1016\/j.thromres.2019.08.020_bb0010","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1182\/blood-2018-04-791541","article-title":"Testing and monitoring direct oral anticoagulants","volume":"132","author":"Connors","year":"2018","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.thromres.2019.08.020_bb0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.chest.2016.08.1462","article-title":"Laboratory assessment of the anticoagulant activity of direct oral anticoagulants: a systematic review","volume":"151","author":"Samuelson","year":"2017","journal-title":"Chest."},{"issue":"2","key":"10.1016\/j.thromres.2019.08.020_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/jth.13912","article-title":"Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians","volume":"16","author":"Douxfils","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.08.020_bb0025","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2147\/DDDT.S45644","article-title":"New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness","volume":"8","author":"Mani","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"issue":"28","key":"10.1016\/j.thromres.2019.08.020_bb0030","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/eurheartj\/eht557","article-title":"Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC Registry","volume":"35","author":"Beyer-Westendorf","year":"2014","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.thromres.2019.08.020_bb0035","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1182\/blood-2014-03-563577","article-title":"Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry","volume":"124","author":"Beyer-Westendorf","year":"2014","journal-title":"Blood."},{"issue":"4","key":"10.1016\/j.thromres.2019.08.020_bb0040","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/bcp.12391","article-title":"Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care\u2014results from the Dresden NOAC registry","volume":"78","author":"Beyer-Westendorf","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.thromres.2019.08.020_bb0045","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/ijlh.12528","article-title":"Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays","volume":"38","author":"Gosselin","year":"2016","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.thromres.2019.08.020_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12959-017-0160-2","article-title":"Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation","volume":"16","author":"Henskens","year":"2018","journal-title":"Thromb. J."},{"issue":"10","key":"10.1016\/j.thromres.2019.08.020_bb0055","first-page":"1611","article-title":"Multianalyte determination of NOACs using LC-MS\/MS and comparison with functional coagulation assays","volume":"64","author":"Slavik","year":"2018","journal-title":"Clin. Lab."},{"issue":"4","key":"10.1016\/j.thromres.2019.08.020_bb0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/ijlh.12846","article-title":"Measurement of rivaroxaban concentrations demonstrates lack of clinical utility of a PT, dPT and APTT test in estimating levels","volume":"40","author":"Thom","year":"2018","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.thromres.2019.08.020_bb0065","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2147\/VHRM.S126265","article-title":"Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants","volume":"13","author":"Ten Cate","year":"2017","journal-title":"Vasc. Health Risk Manag."},{"issue":"20","key":"10.1016\/j.thromres.2019.08.020_bb0070","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1182\/blood-2012-12-453076","article-title":"The laboratory and the direct oral anticoagulants","volume":"121","author":"Tripodi","year":"2013","journal-title":"Blood."},{"issue":"2","key":"10.1016\/j.thromres.2019.08.020_bb0075","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/ijlh.12950","article-title":"Influence of DOAC Stop on coagulation assays in samples from patients on rivaroxaban or apixaban","volume":"41","author":"Platton","year":"2019","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.thromres.2019.08.020_bb0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2019.04.028","article-title":"Clotting test results correlate better with DOAC concentrations when expressed as a \u201cCorrection Ratio\u201d; results before\/after extraction with the DOAC Stop reagent","volume":"179","author":"Exner","year":"2019","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2019.08.020_bb0085","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11239-018-1793-0","article-title":"Assessment of direct oral anticoagulant assay use in clinical practice","volume":"47","author":"Gu","year":"2019","journal-title":"J. Thromb. Thrombolysis"},{"issue":"19","key":"10.1016\/j.thromres.2019.08.020_bb0090","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009807","article-title":"Limitations of specific coagulation tests for direct oral anticoagulants: a critical analysis","volume":"7","author":"Ebner","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"16","key":"10.1016\/j.thromres.2019.08.020_bb0095","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.thromres.2019.08.020_bb0100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13054-017-1619-z","article-title":"Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants","volume":"21","author":"Ebner","year":"2017","journal-title":"Crit. Care"},{"issue":"3","key":"10.1016\/j.thromres.2019.08.020_bb0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-0038-1668098","article-title":"Detecting anti-IIa and anti-Xa direct oral anticoagulant (DOAC) agents in urine using a DOAC dipstick","volume":"45","author":"Harenberg","year":"2019","journal-title":"Semin. Thromb. Hemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384819303500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384819303500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:40:08Z","timestamp":1758735608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384819303500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":21,"alternative-id":["S0049384819303500"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2019.08.020","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DTI\/DXI interferences with global coagulation tests in emergency hospital admissions - Results of the prospective Dresden NOAC Registry (NCT01588119)","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2019.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}